|
|
 |
|
Viewing report
|
|
|
|
Bulletin: Cardinal Health Inc. Ratings Unaffected By DEA Suspension Of Florida Facility Distribution License Feb 12
Standard & Poors, Feb 2012
Abstract
BOSTON (Standard & Poor's) Feb. 10, 2012--Standard & Poor's Ratings Services said today that its ratings on Ohio-based health care distributor Cardinal Health Inc. (A-/Stable/A-2) are unaffected by the Drug Enforcement Administration's (DEA) suspension of the company's license to distribute controlled medicines from its Lakeland, Fla. distribution center. The suspension was due to high quantities of oxycodone sales to four of Cardinal Health's Florida pharmacy customers, which the DEA believes could be involved in a scheme to illegally redistribute the drugs. Cardinal Health has since been granted a temporary restraining order on the DEA's suspension from the U.S. District Court for the District of Columbia, which allows the company to continue to ship controlled medicines from Lakeland. The court order...
Companies mentioned in this report are: Cardinal Health Inc.
Action: Bulletin
Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.
Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.
|
|
|
|
